Cardior Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingLower Saxony, Germany11-50 Employees
Cardior Pharmaceuticals is a clinical-stage biopharmaceutical company developing RNA-based therapies for heart disease. It relies on a platform built around distinctive non-coding RNAs to address the underlying causes of cardiac dysfunction, with programs aimed at preventing, repairing, or reversing disease processes. As of May 2, 2024, Cardior Pharmaceuticals GmbH is a wholly owned subsidiary of Novo Nordisk Region Europe A/S. One clinical program, HF-REVERT, evaluates CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction. Its work focuses on advancing RNA-based therapeutics and diagnostics for cardiac diseases, with the goal of improving patient outcomes.